REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations
This study has been completed.
Information provided by:
First received: June 30, 2005
Last updated: December 4, 2008
Last verified: December 2008
The purpose of this study is to determine if Enbrel® or Kineret® will have a positive effect on subject functionality as measured by the Health Assessment Questionnaire Disability Index (HAQDI).
|Study Design:||Time Perspective: Prospective|
|Official Title:||Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations (REKinDLE)|
Resource links provided by NLM:
U.S. FDA Resources
Further study details as provided by Amgen:
Contacts and Locations